Dr. Ludger Dinkelborg

Managing Director, Imaging

Dr. Ludger Dinkelborg leads the Imaging Division of Piramal Enterprises. This section was created through the acquisition of worldwide rights for the Molecular Imaging Research and Development Portfolio of Bayer Pharma AG.

Before co-founding Piramal Imaging, Dr. Ludger served as Head of Diagnostic Imaging Research and Head of Molecular Imaging at Bayer HealthCare. He has more than 20 years of R&D experience in the pharmaceutical industry.

He received his PhD in Biology at Heinrich-Heine-University, Düsseldorf, and continued as guest researcher at the Max-Planck-Institute for Molecular Physiology in Dortmund. He became a fellow of the Konrad-Adenauer-Foundation, attended the Cranfield Schering University course for managers and also attended the Executive Program at Stanford School of Business, CA.

Ajay Piramal

Chairman, Piramal Group & Shriram Group

Nandini Piramal

Executive Director, Piramal Enterprises Ltd.

Vijay Shah

Executive Director, Piramal Enterprises
Director, Piramal Glass
Chairman, Piramal Glass Ceylon Plc.

Khushru Jijina

Managing Director, Piramal Finance Ltd.
Managing Director, Piramal Housing Finance Ltd

Vivek Sharma

CEO, Pharma Solutions, Piramal Enterprises Ltd

Kedar Rajadnye

President & Chief Operating Officer - Consumer Products, Piramal Enterprises Ltd.
IT Head, Piramal Group

Peter DeYoung

CEO, Critical Care, Piramal Enterprises Ltd.

Harinder S. Sikka

Group Director – Strategic Business

Jonathan Sandler

CEO, Decision Resources Group

Shantanu Nalavadi

Managing Director, Piramal Bain Resurgence Fund

Anand Piramal

Executive Director, Piramal Group

Srinivas Chunduru

Executive Director, Piramal Housing Finance Ltd

Paresh Parasnis

CEO, Piramal Foundation

Management Advisors

Shikhar Ghosh

Professor, Harvard Business School

Nitin Nohria

Dean, Harvard Business School